{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:16:37Z","timestamp":1790435797049,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["226-2023-00151"],"award-info":[{"award-number":["226-2023-00151"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ24H160028"],"award-info":[{"award-number":["LQ24H160028"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2025.117660","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:43:27Z","timestamp":1766130207000},"page":"117660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MEK inhibitor induces cardiac complications by preventing ZMYND8-mediated ubiquitination and proteasomal degradation of HMGB1"],"prefix":"10.1016","volume":"245","author":[{"given":"Huangxi","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taicheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1896-097X","authenticated-orcid":false,"given":"Zhifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bcp.2025.117660_b0005","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"21","key":"10.1016\/j.bcp.2025.117660_b0010","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","article-title":"Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in patients with Breast Cancer","volume":"139","author":"Kitani","year":"2019","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.bcp.2025.117660_b0015","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/CIRCULATIONAHA.120.049210","article-title":"Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase","volume":"142","author":"Xiao","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bcp.2025.117660_b0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCRESAHA.123.323683","article-title":"Integrated stress Response Potentiates Ponatinib-Induced Cardiotoxicity","volume":"134","author":"Yan","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117660_b0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-pharmtox-030620-104842","article-title":"Preventing and Treating Anthracycline Cardiotoxicity: New Insights","volume":"61","author":"Sawicki","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117660_b0030","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.121.058411","article-title":"Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy","volume":"146","author":"Dhingra","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2025.117660_b0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.122.322264","article-title":"PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth","volume":"133","author":"Chen","year":"2023","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.bcp.2025.117660_b0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41577-023-00894-6","article-title":"The multifunctional protein HMGB1: 50 years of discovery","volume":"23","author":"Tang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"6894","key":"10.1016\/j.bcp.2025.117660_b0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117660_b0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41401-018-0044-4","article-title":"PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bcp.2025.117660_b0060","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1080\/15548627.2021.1965712","article-title":"Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib","volume":"18","author":"Xu","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2025.117660_b0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxlet.2018.08.003","article-title":"High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity","volume":"296","author":"Xu","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2025.117660_b0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-023-01854-3","article-title":"Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches","volume":"22","author":"Hasan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117660_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2025.109025","article-title":"Evolving treatment paradigms for melanoma brain metastases: a systematic review of current modalities","volume":"257","author":"Grant","year":"2025","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12012-017-9425-z","article-title":"Cardiovascular Effects of the MEK Inhibitor, Trametinib: a Case Report, Literature Review, and Consideration of Mechanism","volume":"17","author":"Banks","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117660_b0095","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jtho.2021.07.030","article-title":"Pharmacovigilance Analysis of Cardiac Toxicities Associated with Targeted Therapies for Metastatic NSCLC","volume":"16","author":"Waliany","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117660_b0100","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1002\/cam4.3938","article-title":"Cardiovascular adverse events associated with BRAF versus BRAF\/MEK inhibitor: Cross-sectional and longitudinal analysis using two large national registries","volume":"10","author":"Guha","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.1893","article-title":"A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy","volume":"15","author":"Lorenz","year":"2009","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaccao.2022.07.009","article-title":"Cellular and Molecular Mechanisms of MEK1 Inhibitor-Induced Cardiotoxicity","volume":"4","author":"Beck","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"26","key":"10.1016\/j.bcp.2025.117660_b0115","article-title":"Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL","volume":"10","author":"Yan","year":"2023","journal-title":"Adv Sci (weinh)"},{"key":"10.1016\/j.bcp.2025.117660_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2025.117660_b0130","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00204-016-1918-1","article-title":"Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria","volume":"91","author":"Zhang","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"20","key":"10.1016\/j.bcp.2025.117660_b0135","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117660_b0140","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.biopha.2017.03.022","article-title":"Pre-conditioning with tanshinone IIA attenuates the ischemia\/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells","volume":"89","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bcp.2025.117660_b0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1165\/rcmb.2008-0119OC","article-title":"Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function","volume":"41","author":"Tang","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s10020-022-00596-0","article-title":"USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity","volume":"28","author":"Shin","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2025.117660_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.761346","article-title":"Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1\/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma","volume":"11","author":"Yao","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-017-00299-9","article-title":"An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"issue":"D1","key":"10.1016\/j.bcp.2025.117660_b0165","doi-asserted-by":"crossref","first-page":"D719","DOI":"10.1093\/nar\/gkab962","article-title":"UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/15384101.2017.1376150","article-title":"Double duty: ZMYND8 in the DNA damage response and cancer","volume":"17","author":"Gong","year":"2018","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/j.bcp.2025.117660_b0175","article-title":"Biohybrid 3D Printing of a Tissue-Sensor Platform for Wireless, Real-Time, and Continuous monitoring of Drug-Induced Cardiotoxicity","volume":"35","author":"Yong","year":"2023","journal-title":"Adv. Mater."},{"issue":"D1","key":"10.1016\/j.bcp.2025.117660_b0180","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaccao.2019.08.003","article-title":"Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer","volume":"1","author":"Macedo","year":"2019","journal-title":"JACC CardioOncol"},{"issue":"12","key":"10.1016\/j.bcp.2025.117660_b0190","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1200\/JCO.22.02423","article-title":"Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer","volume":"41","author":"Chow","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117660_b0195","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2025.2576619","article-title":"Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity","author":"Gao","year":"2025","journal-title":"Autophagy"},{"issue":"9992","key":"10.1016\/j.bcp.2025.117660_b0200","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bcp.2025.117660_b0205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00395-016-0566-1","article-title":"Regulator of G protein signalling 14 attenuates cardiac remodelling through the MEK-ERK1\/2 signalling pathway","volume":"111","author":"Li","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0215","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"issue":"17","key":"10.1016\/j.bcp.2025.117660_b0220","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117660_b0225","first-page":"789","article-title":"MEK Inhibition for RASopathy-Associated Hypertrophic Cardiomyopathy: Clinical Application of a Basic Concept","volume":"40","author":"Chaput","year":"2024","journal-title":"Can. J. Cardiol."},{"issue":"14","key":"10.1016\/j.bcp.2025.117660_b0230","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2023.02.010","article-title":"MEK Inhibition Improves Cardiomyopathy in Costello Syndrome","volume":"81","author":"Geddes","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152922","article-title":"Modulation of Macrophage Polarization and HMGB1-TLR2\/TLR4 Cascade Plays a crucial Role for Cardiac Remodeling in Senescence-Accelerated Prone mice","volume":"11","author":"Karuppagounder","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117660_b0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2022.08.035","article-title":"LRRK2 deficiency protects the heart against myocardial infarction injury in mice via the P53\/HMGB1 pathway","volume":"191","author":"Liu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2025.117660_b0245","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fimmu.2020.01104","article-title":"HMGB1\/PI3K\/Akt\/mTOR Signaling Participates in the Pathological Process of Acute Lung Injury by Regulating the Maturation and Function of Dendritic Cells","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117660_b0250","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.1316925111","article-title":"JAK\/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bcp.2025.117660_b0255","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41388-021-02167-9","article-title":"Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bcp.2025.117660_b0260","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171166","article-title":"ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2","volume":"134","author":"Luo","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117660_b0265","doi-asserted-by":"crossref","unstructured":"Z. Cao, K.A. Budinich, H. Huang, D. Ren, B. Lu, Z. Zhang, Q. Chen, Y. Zhou, Y.H. Huang, F. Alikarami, M.C. Kingsley, A.K. Lenard, A. Wakabayashi, E. Khandros, W. Bailis, J. Qi, M.P. Carroll, G.A. Blobel, R.B. Faryabi, K.M. Bernt, S.L. Berger, J. Shi, ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency, Mol Cell 81(17) (2021) 3604-3622 e10.","DOI":"10.1016\/j.molcel.2021.07.018"},{"issue":"9","key":"10.1016\/j.bcp.2025.117660_b0270","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.gim.2022.06.001","article-title":"De Novo ZMYND8 variants result in an autosomal dominant neurodevelopmental disorder with cardiac malformations","volume":"24","author":"Dias","year":"2022","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117660_b0275","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.apsb.2015.05.005","article-title":"The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb","volume":"5","author":"Wang","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.bcp.2025.117660_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.01.011","article-title":"Bio-soft matter derived from traditional chinese medicine: Characterizations of hierarchical structure, assembly mechanism, and beyond","volume":"14","author":"Yang","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bcp.2025.117660_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152508","article-title":"Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt\/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity","volume":"441","author":"Lv","year":"2020","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117660_b0290","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/jcmm.14703","article-title":"Glycyrrhizin mitigates radiation-induced acute lung injury by inhibiting the HMGB1\/TLR4 signalling pathway","volume":"24","author":"Zheng","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117660_b0295","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4330\/wjc.v16.i11.619","article-title":"Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure","volume":"16","author":"Shah","year":"2024","journal-title":"World J. Cardiol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225009256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225009256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:11:50Z","timestamp":1781698310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225009256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":59,"alternative-id":["S0006295225009256"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117660","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEK inhibitor induces cardiac complications by preventing ZMYND8-mediated ubiquitination and proteasomal degradation of HMGB1","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117660"}}